JE. Jackson, R. Bressler, Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1., in Drugs, vol. 22, n. 3, Set 1981, pp. 211-45, PMID7021124.
MS. Greenfield, L. Doberne; M. Rosenthal; B. Schulz; A. Widstrom; GM. Reaven, Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus., in Diabetes, vol. 31, 4 Pt 1, aprile 1982, pp. 307-12, PMID6759246.
TH. Sullivan-Klose, BI. Ghanayem; DA. Bell; ZY. Zhang; LS. Kaminsky; GM. Shenfield; JO. Miners; DJ. Birkett; JA. Goldstein, The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism., in Pharmacogenetics, vol. 6, n. 4, Ago 1996, pp. 341-9, PMID8873220.
JH. Shon, YR. Yoon; KA. Kim; YC. Lim; KJ. Lee; JY. Park; IJ. Cha; DA. Flockhart; JG. Shin, Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans., in Pharmacogenetics, vol. 12, n. 2, marzo 2002, pp. 111-9, PMID11875365.
DH. Gregory, GF. Zaki; GA. Sarcosi; JB. Carey, Chronic cholestasis following prolonged tolbutamide administration., in Arch Pathol, vol. 84, n. 2, Ago 1967, pp. 194-201, PMID21936121.
JV. Ananth, TA. Ban; HE. Lehmann, Tolbutamide jundice associated with multiple drug therapy., in Can Med Assoc J, vol. 103, n. 11, novembre 1970, p. 1194, PMID5489326.
GW. Bird, GH. Eeles; JA. Litchfield; M. Rahman; J. Wingham, Haemolytic anaemia associated with antibodies to tolbutamide and phenacetin., in Br Med J, vol. 1, n. 5802, marzo 1972, pp. 728-9, PMID4622619.
JE. Jackson, R. Bressler, Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2., in Drugs, vol. 22, n. 4, Ott 1981, pp. 295-320, PMID7030708.
E. Schulz, [Severe hypoglycemia reactions following treatment with tolbutamide, carbutamide and chlorpropamide (report on 14 cases, studies on clinical symptoms and pathogenesis)]., in Arch Klin Med, vol. 214, n. 2, 1968, pp. 135-62, PMID5718735.
M. Pokorski, [A case of severe recurrent hypoglycemia after suicidal poisoning with tolbutamide]., in Wiad Lek, vol. 22, n. 1, gennaio 1969, pp. 63-8, PMID5788836.
J. Bures, B. Fixa; V. Kaut; V. Herout; Z. Hrncír, [Severe hypoglycemia due to Dirastan (tolbutamide) in a diabetic with chronic renal failure]., in Vnitr Lek, vol. 28, n. 7, Lug 1982, pp. 678-84, PMID7112992.
PK. Kar, SK. Das Gupta; KD. Das, Tolbutamide photosensitivity., in J Indian Med Assoc, vol. 82, n. 8, Ago 1984, pp. 289-91, PMID6491339.